Cited by 191Viral Infections and Immunology ResearchSystemic Lupus Erythematosus ResearchAutoimmune Neurological Disorders and Treatments

Circulating heart-reactive antibodies in patients with myocarditis or cardiomyopathy

Open access
Neumann, David A., Lynne Burek, C., Baughman, Kenneth L., Rose, Noel R., Herskowitz, Ahvie·1990·Journal of the American College of Cardiology

Abstract

Heart-reactive antibodies are commonly observed in patients with myocarditis or cardiomyopathy. Such antibodies may be important in the pathogenesis of these disorders, yet the specific antigens recognized have not been studied systematically. This report characterizes circulating heart autoantibodies from patients with myocarditis (n = 17) or idiopathic cardiomyopathy (n = 71) and from healthy volunteers (n = 15). Indirect immunofluorescence demonstrated that high titer (greater than or equal to 1:20) immunoglobulin G (IgG) antibody activity occurred in 59% of the myocarditis samples, 20% of the cardiomyopathy samples and none of the normal samples. All samples were tested by Western immunoblotting for IgG activity against a normal human heart extract. The number of antigens recognized by each sample was enumerated and the molecular weight of each antigen estimated; the prevalence of reactivity against antigens in selected molecular weight classes was determined. There was no difference in the mean number of heart antigens recognized by serum from each group. For most weight classes, prevalence either did not differ significantly among the various groups or subgroups or was greatest among samples from healthy volunteers. Prevalence of reactivity with 190 to 199 kilodalton (kd) antigens was greatest (p less than 0.05) among low titer serum samples from patients with myocarditis. High titer cardiomyopathy serum differed from normal serum by an increased (p less than 0.05) prevalence of antibodies to 40 to 49 and 100 to 109 kd antigens. These results suggest that western immunostaining may ultimately contribute substantively to identifying patients with myocarditis or cardiomyopathy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(10)80331-6

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elevated levels of antimyosin autoantibodies are present in the serum of myocarditis patients and murine models, as well as in other cardiovascular disease conditions.

    “an elevated level of antimyosin autoantibodies in the serum of both myocarditis patients and murine models, as well as in other cardiovascular disease conditions”

    From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [87]

    The opening report (page not indexed) finds high-titer heart-reactive antibodies in 59% of myocarditis patients, but does not establish that those antibodies target myosin. The Technical considerations section reports antibodies against cardiac myosin in murine myocarditis models, and Induction of heart-reactive antibodies discusses antimyosin antibodies in other cardiac conditions. Thus the murine and other-condition portions are supported, but the claim of elevated antimyosin antibodies in the patients studied is not. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 191

Research works printed but not linked: 22

  1. I. Maisch B, Berg PA. Kochsiek K. Autoantibodies and serum inhibition factors (SIF) in patients with myocarditis. Klin Wochenschr 1980;58: 219-25.
  2. Maisch B, Maisch S. Kochsiek K. Immune reactions in tuberculous and chronic constrictive pericarditis: clinical data and diagnostic significance of antimyocardial antibodies. Am J Cardiol 1982;50: 1007-13.
  3. Maisch B. Trostel-Soeder R, Stechemesser E. Berg PA. Kochsiek K. Diagnostic relevance of humoral and cell-mediated immune reactions in patients with acute viral myocarditis. C1in Exp ImmunoI1982;48:533-45.
  4. Schultheiss H-P. Bolte H-D. Immunological analysis of autoantibodies against the adenine nucleotide translocator in dilated cardiomyopathy. J Mol Cell CardioI1985;17:603-17.
  5. Schultheiss H-P. Klingenberg M. Immunochemical characterization of the adenine nucleotide translocator: organ and conformation specificity. Eur J Biochem 1984;143:599-605.
  6. Schultheiss H-P. Schulze K, Kuhl U, Ulrich G, Klingenberg M. The ADP/ATP carrier as a mitochondrial auto-antigen: facts and perspectives. Ann N Y Acad Sci 1986;488:44-63.
  7. II. Szarfman A. Terranova VP, Rennard SI, et al. Antibodies to laminin in Chagas' disease. J Exp Med 1982;155: 1161-71.
  8. Neu N, Beisel KW. Traystman MD. Rose NR, Craig SW. Autoantibodies specific for the cardiac myosin isoform are found in mice susceptible to Coxsackievirus B)-induced myocarditis. 1 ImmunoI1987;138:2488-92.
  9. Plotz PH. Autoantibodies are anti-idiotype antibodies to antiviral antibod- ies. Lancet 1983;2:824-6.
  10. Paque RE. Miller R. Modulation of murine coxsackievirus-induced my- ocarditis utilizing anti-idiotypes. Viral Immunol 1987;1 :207-24.
  11. Ulrich G. Kuhl U. Melzner B. landa I. Schafer B, Schultheiss H-P. Antibodies against the adenosine di/triphosphate carrier cross-react with the Ca channel: functional and biochemical data. In: Schultheiss H-P. ed. New Concepts in Viral Heart Disease. Berlin: Springer-Verlag, 1988: 225-35.
  12. Aretz HT. Myocarditis: the Dallas criteria. Human Pathol 1987;18:619- 24.
  13. Hames BO. Rickwood D. Gel Electrophoresis of Proteins. Oxford: IRL, 1981 :72-3.
  14. Andrews AT. Electrophoresis: Theory. Techniques. and Biochemical and Clinical Applications. Oxford: Clarendon, 1986: 108-10.
  15. Lompre AM. Mercadier 11. Wisnewsky C. et al. Species-and age- dependent changes in the relative amounts of cardiac myosin isoenzymes in mammals. Develop BioI 1981;84:286-90. AUTOANTIBODIES IN MYOCARDITIS/CARDIOMYOPATHY JACC Vol. 16, No.4 October 1990:839-46 29. Mercadier 11, Lompre A•M, Wisnewsky C, et al. Myosin isoenzymic changes in several models of rat cardiac hypertrophy. Circ Res 1981 ;49: 525-32.
  16. Dressler W. The post-myocardial-infarction syndrome: a report on forty- four cases. Arch Intern Med 1959;103:28-42.
  17. Heine WI, Friedman H, Mandell MS, Goldberg H. Antibodies to cardiac tissue in acute ischemic heart disease. Am J Cardiol 1966;17:798-803.
  18. Wolfgram LJ, Beisel KW, Rose NR. Heart-specific autoantibodies fol- lowing murine coxsackievirus B, myocarditis. J Exp Med 1985;161: 1112-21. .
  19. Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR. Variations in the susceptibility of coxsackievirus B)-induced myocarditis among different strains of mice. J ImmunoI1986;136:1846-52.
  20. Brewerton DA. HLA-B27 and the inheritance of susceptibility to rheu- matic disease. Arth Rheum 1976;19:656-68.
  21. Rache1efsky GS, Terasaki PI, Katz R, Steim ER. Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med 1974;290:892-3.
  22. Harley lB, Reichlin M. Arnett FC, Alexander EL, Bias WB, Provost IT. Gene interaction at HLA-DQ enhances autoantibody production in pri- mary Sjogren's syndrome. Science 1986;232:1145-7.

Authors
Neumann, D. A., Lynne Burek, C., Baughman, K. L., Rose, N. R., & Herskowitz, A.
Affiliations
Johns Hopkins University (US)
Corresponding author
Neumann, David A.
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
1990-10
Volume
16
Issue
4
Pages
839-846
ISSN
0735-1097 (ISSN-L)
OpenAlex
W2015543995
Cited by
191
References
40
Citations by year
2026: 3 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 5 · 2016: 1 · 2015: 2 · 2014: 5 · 2013: 3 · 2012: 5
FWCI
5.27
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01hl034744-04)
  • National Heart, Lung, and Blood Institute (HL34744)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
  • Health Sciences › Medicine › Neurology › Autoimmune Neurological Disorders and Treatments
Keywords
myocarditis, idiopathic cardiomyopathy, serum autoantibodies, IgG, autoantibody prevalence, autoantibody titers, disease diagnosis
MeSH terms
Adolescent, Adult, Aged, Antibodies, Child, Female, Fluorescent Antibody Technique, Heart Diseases, Humans, Immunoglobulin G, Male, Middle Aged, Molecular Weight, Myocarditis, Blotting, Western

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review